Key result
Nurse-led heparin algorithm achieves ~20-hour CRRT circuit life without adverse events.
Why the study?
Premature circuit clotting during continuous renal replacement therapy is a clinical problem requiring effective anticoagulation strategies.
Does an individualized unfractionated heparin algorithm allow effective and safe nurse-led anticoagulation during continuous renal replacement therapy?
Does an individualized unfractionated heparin algorithm allow effective and safe nurse-led anticoagulation during continuous renal replacement therapy?
An individualized unfractionated heparin algorithm based on bleeding risk and circuit life enables safe and effective nurse-led anticoagulation during continuous renal replacement therapy.
Answers are grounded in this paper and cite their sources.
May support nurse-led UFH anticoagulation in CRRT; hypothesis-generating and requires prospective validation before practice change.
Premature circuit clotting is a problem during continuous renal replacement therapy. We describe an algorithm for individualised anticoagulation with unfractionated heparin based on the patient's risk of bleeding and previous circuit life. The algorithm allows effective and safe nurse-led anticoagulation during continuous renal replacement therapy.
No takes yet. Share an insight, caveat, or question.
Ostermann et al. (2010) conducted a letter in Acute kidney injury requiring continuous renal replacement therapy. Unfractionated heparin algorithm was evaluated on Mean circuit life. Implementation of a nurse-led unfractionated heparin algorithm for continuous renal replacement therapy resulted in a mean circuit life of 19.8 hours without any untoward incidents.
Synapse has enriched 10 related papers. Consider them for comparative context: